Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries - 2The Best Portable Applications for Emotional wellness and Prosperity
- 3The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- 4How much would you pay to meet a Real Housewife? At BravoCon, the limit does not exist.
- 5Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- Current Chateaus: Advancement and Style
- Five held on suspicion of planning attack on German Christmas market
- Antivirus Programming for Exhaustive Security
- Must-Sit in front of the Programs from Europe and the US
- Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
- French Senate debates social media ban for under-15s
- ‘It’s Israeli policy’: Report reveals abuse of Palestinians in prisons
- 4 African Vacationer Locations
- Ariana Grande says Eternal Sunshine 2026 tour will be her last for a 'long, long time': 'One last hurrah'
